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Abstract
Vesicles of phosphatidylcholine/cholesterol mixtures show a wide composition range with coexistence of two fluid phases,
the ‘liquid disordered’ (cholesterol-poor) and ‘liquid ordered’ (cholesterol-rich) phases. These systems have been widely used
as models of membranes exhibiting lateral heterogeneity (membrane domains). The distributions of two fluorescent probes (a
fluorescent cholesterol analog, NBD-cholesterol, and a lipophilic rhodamine probe, octadecylrhodamine B) in
dimyristoylphosphatidylcholine/cholesterol vesicles were studied, at 30‡C and 40‡C. The steady-state fluorescence intensity
of both probes decreases markedly with increasing cholesterol concentration, unlike the fluorescence lifetimes. The liquid
ordered to liquid disordered phase partition coefficients Kp were measured, and values much less than unity were obtained
for both probes, pointing to preference for the cholesterol-poor phase. Globally analyzed time-resolved energy transfer
results confirmed these findings. It is concluded that, in particular, NBD-cholesterol is not a suitable cholesterol analog and
its distribution behavior in phosphatidylcholine/cholesterol bilayers is in fact opposite to that of cholesterol. ß 2001
Elsevier Science B.V. All rights reserved.
Keywords: Model membrane; Cholesterol ; Phase separation; Fluorescence; Energy transfer; Fluorescence resonance energy transfer;
Partition; Fluorescent probe
1. Introduction
The detection and characterization of lipid micro-
domains is a major topic in membrane biophysics,
because of their possible role in various biochemical
functions [1]. While microscopic techniques with
nanometer resolution are still under development,
the most promising approaches to this problem are
probably spectroscopic methods, such as photophys-
ical techniques. These include measurement of £uo-
rescence intensity, lifetimes and anisotropy [2], and
time-resolved £uorescence resonance energy transfer
(FRET). The latter has been used for the study of
phase separation and domain formation in model
membranes only very recently [3,4].
In this work, we studied dimyristoylphosphatidyl-
choline (DMPC)/cholesterol mixtures, which show
phase separation of the liquid ordered (lo)/liquid dis-
ordered (ld) type, probably relevant to biological
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membranes [5], using £uorescence techniques. The
two probes used, 22-(7-nitrobenz-2-oxa-1,3-diazol-4-
yl-amino)-23,24-bisnor-5-colen-3L-ol (NBD-choles-
terol) and octadecylrhodamine B (ORB), form a do-
nor/acceptor FRET pair. The NBD/rhodamine pair
is a very common choice for FRET studies in mem-
branes [3,6^10], and the use of a £uorescent sterol
analog as donor and an acceptor bearing a long alkyl
chain would in principle allow the study of phase
separation in this system, similarly to a previous
study in a gel/£uid heterogeneous system [4]. NBD-
cholesterol is the most commonly used £uorescent
analog of cholesterol, and has been used as such in
numerous studies in the past (very recent examples
being [11,12]). However, some reports have hinted
at an unusual membrane distribution behavior of
sterols labeled with a NBD moiety [13,14]. This
prompted us to carry out a detailed spectroscopic
study in this paper. Fig. 1 shows the lipid phase
diagram (the studied systems are highlighted) and
the probes’ structures.
2. Materials and methods
NBD-cholesterol and ORB were purchased from
Molecular Probes (Eugene, OR, USA). DMPC was
obtained from Avanti Polar Lipids (Birmingham,
AL, USA) and cholesterol was obtained from Merck
(Darmstadt, Germany). All materials were used as
received.
Preparation of the model membranes, large unila-
mellar vesicles (LUV), was carried out using the ex-
trusion method [15]. Successful incorporation of
ORB was achieved by injection of small amounts
of methanol solution to previously prepared LUV
[16], while for NBD-cholesterol small amounts of
probe methanolic solution were mixed with the
non-£uorescent lipid stock solutions in chloroform
before hydration and extrusion, to ensure complete
incorporation in the membranes.
The instrumentation for the £uorescence measure-
ments has been described elsewhere in detail [4]. For
NBD-cholesterol decays, excitation was at 340 nm
and emission at 520 nm, while for ORB excitation
was at 570 nm and emission at 610 nm. The good-
ness of ¢ts to the decays was judged from the indi-
vidual experiments’ M2 values and weighted residuals
and autocorrelation plots. Even in the absence of
FRET, the observed decays were generally complex,
and successful analysis required a sum of up to three
exponential terms. Average lifetimes, Gdf, were calcu-
lated from [17]:
Gdf 
X
i
Aid 2i =
X
i
Aid i 1
where di are the decay lifetime components and
Ai are their respective normalized amplitudes. Flu-
Fig. 1. (Left) Structures of the £uorescent probes used. (Right) DMPC/cholesterol phase diagram [5], highlighting the studied composi-
tions and temperatures.
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orescence steady-state measurements were carried
out with a SLM-Aminco 8100 Series 2 spectro-
£uorimeter. Absorption spectra were measured in
a Jasco V-560 spectrophotometer. Critical distances
for energy transfer, R0, were calculated from (e.g.
[18]):
R0  0:2108W U 2WxDWn34W
Z r
0
IV WO V WV 4WdV
 
1=6
2
where xD is the donor quantum yield, O(V) is the
acceptor molar absorption coe⁄cient, U2 is the ori-
entation factor, n is the refractive index (taken as 1.4,
an average between the values in water and in the
bilayer interior [19]), and V is the wavelength. If the V
units used in Eq. 2 are nm, the calculated R0 has Aî
units. The major source of uncertainty in the calcu-
lation of R0 is often the orientation factor. In this
work, we used U2 = 2/3, the dynamic isotropic limit
value. Of course, the bilayer is not an isotropic me-
dium. However, because the studied systems are
composed of two £uid lipid phases, the dynamic limit
is expected to be valid. This has been veri¢ed for
lipophilic probes in the ld phase [16], and is also
expected for the lo phase, in which the NBD-choles-
terol £uorescence anisotropy is only slightly higher
than in the ld phase (0.14 in the ld phase and 0.18 in
the lo phase for T = 40‡C). In this situation, U2 (and
thus R0) is expected to have an almost constant value
for all donor^acceptor pairs.
3. Results
3.1. Probe photophysics
3.1.1. NBD-cholesterol
Fig. 2 shows the corrected excitation and emission
spectra of NBD-cholesterol (0.1 mol%) in DMPC/
cholesterol LUV at 30‡C (identical trends were ob-
served at T = 40‡C). The most striking feature is the
large decrease in £uorescence intensity with increas-
ing cholesterol molar fraction, xchol (by a factor of
V5 in the 09 xchol9 0.40 range). Both excitation
and emission spectra show a blue shift for high xchol.
NBD-cholesterol shows complex £uorescence de-
cays in DMPC/cholesterol LUV in the absence of
ORB, and three lifetime components (d1V1 ns,
d2V4 ns, d3V9 ns) were needed to analyze most
samples. At variance with the steady-state intensity,
the maximum variation in Gdf for the studied samples
is relatively small (V5%; result not shown).
Fig. 3 shows the variation of £uorescence intensity
(IF) of NBD-cholesterol as a function of xchol. This
variation can be used to determine the lo to ld phase
partition coe⁄cient, Kp, de¢ned as [2] :
Kp  Plo=X lo=Pld=X ld 3
where Plo is the probe molar fraction in the lo phase,
and Xlo is the lo molar fraction (with Pld = 13Plo and
Xld = 13Xlo having an identical meaning for the ld
phase). The relationship between IF and the probe
fraction within each phase for dilute samples (total
Fig. 2. Excitation (A; Vemission = 560 nm) and emission (B; Vexcitation = 334 nm) spectra of NBD-cholesterol (0.1 mol%) in DMPC/cho-
lesterol LUV, T = 30‡C, for several cholesterol concentrations (indicated).
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absorbance 6 0.1) is given by (e.g. [4]) :
IF  K WPldWO ldWx ld  PloWO loWx lo 4
where K includes a geometric factor and the intensity
of excitation light. Using Plo/Pld = KpW(13Xld)/Xld,
there are only two ¢tting variables, K and Kp. The
solid curves in Fig. 3 were obtained in this way,
Kp(30‡C) = 0.35 and Kp(40‡C) = 0.39 being recovered.
3.1.2. ORB
Fig. 4 shows the absorption (T = 22‡C) and cor-
rected emission (T = 30‡C, similar results being ob-
served for T = 40‡C) of ORB (ORB:total lipid =
0.003) in DMPC/cholesterol LUV. For the absorp-
tion, the spectrum for a sample with the same bulk
concentration in bu¡er is also shown for comparison.
As observed with NBD-cholesterol, there is a signi¢-
cant reduction of absorption (V45%) and emission
(V60%) intensities with increasing xchol (from 0 to
0.4). While the emission spectrum is not shifted, the
absorption maximum changes from 560 nm
(xchol = 0) to 565 nm (xchol = 0.4). In any case, it is
still far from the value observed in bu¡er (582 nm),
where the absorption intensity is equal to that in
pure DMPC (but there is an enhancement in the
shoulder at V540 nm, revealing excitonic interac-
tion; this is absent from the LUV spectra). The emis-
sion in bu¡er (not shown) is V20 times less intense
Fig. 3. Normalized £uorescence intensity (R ; Vexcitation = 467 nm, Vemission = 520 nm) of NBD-cholesterol (0.1 mol%) in DMPC/choles-
terol LUV, T = 30‡C (A) and 40‡C (B), as a function of the lo phase fraction (Xlo). The lines are ¢ts using Eq. 4, with
Kp(30‡C) = 0.35 and Kp(40‡C) = 0.39.
Fig. 4. Absorption (A; room temperature) and emission (B; T = 30‡C; Vexcitation = 515 nm) spectra of ORB (0.3 mol%) in DMPC/cho-
lesterol LUV, for several cholesterol concentrations (indicated).
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than in pure DMPC, and has a maximum at V619
nm, shifted 30 nm from the value observed in LUV.
Two exponentials are needed to analyze the ORB
£uorescence decays for 0.00059ORB:total lipid
9 0.003 and 09xchol9 0.4. The average lifetime of
ORB (ORB:total lipid = 0.0005) is almost constant
as a function of xchol, and equal to 2.2^2.3 ns at
T = 30‡C and 1.7 ns at T = 40‡C. However, it de-
creases with increasing ORB concentration. For
xchol = 0, the relative decrease of Gdf for 0.00059
ORB:total lipid9 0.003 is V5%, while for xchol =
0.40, and despite the smaller typical di¡usion coe⁄-
cients in the lo phase [5], which would lead to less
dynamic self-quenching, the decrease is more pro-
nounced (V15%; results not shown).
Similarly to NBD-cholesterol, Kp were obtained
from the IF variation using Eqs. 3 and 4, and the
values Kp(30‡C) = 0.17 and Kp(40‡C) = 0.43 were re-
covered (see Fig. 5).
3.2. FRET between NBD-cholesterol and ORB
The critical distances for FRET, calculated from
Eq. 2 using the spectroscopic parameters for these
probes, are R0(30‡C) = 44.8 Aî and R0(40‡C) = 42.9
Aî . Due to the LUV preparation procedure, ORB is
expected to be located on the outer monolayer, with
its chromophore on the water region (V3.5 Aî from
the interphase, as determined by Medhage et al. [20]
for another rhodamine lipophilic probe). On the oth-
er hand, the NBD-cholesterol chromophore should
lie in the bilayer interior [21]. Thus, FRET bilayer
geometry will be considered. In this way, the decay
law used for analysis of FRET decay data was [4]:
iDAt  iDtWAldWb ldt  AloWb lot 5
where iD(t) is the decay law of NBD-cholesterol in
the absence of ORB (taken as a sum of three expo-
nentials), Ai is proportional to the amount of donors
in phase i (i = ld, lo) and bi(t) is given by [19]:
b it  exp 3 2ciy 2=3b
Z 1
0
13exp3tb3K 6K33dK
 
6
where ci is proportional to the concentration of ac-
Fig. 5. Normalized £uorescence intensity (b ; Vexcitation = 560 nm, Vemission = 593 nm) of ORB (ORB:total lipid = 0.003) in DMPC/choles-
terol LUV, T = 30‡C (A) and 40‡C (B), as a function of the lo phase fraction (Xlo). The lines are ¢ts using Eq. 4, with
Kp(30‡C) = 0.17 and Kp(40‡C) = 0.43.
Table 1
Fit parameters of FRET decay data to Eqs. 5 and 6, in LUV
of DMPC/cholesterol
T Parameter xchol
0 0.15 0.20 0.25 0.40
30‡C cld 0.37 0.51 0.69 0.72 ^
clo ^ 0 0.06 0.09 0.47
Alo/Ald 0 (¢xed) 0.18 0.64 0.76 r (¢xed)
M2 1.04 1.23 1.09 1.25 1.33
40‡C cld 0.45 0.61 0.63 0.64 ^
clo ^ 0.01 0 0 0.54
Alo/Ald 0 (¢xed) 0.17 0.27 0.28 r (¢xed)
M2 1.28 1.20 1.22 1.24 1.50
Donor: NBD-cholesterol (0.1 mol%); acceptor: ORB (0.5
mol%).
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ceptors in phase i, and b = (R0/d)2/d, where, in turn, d
is the distance between the plane of donors and that
of the acceptors (estimated as 17.8 Aî [20,22]) and d is
the lifetime-weighted quantum yield, given by gAjdj
[17]. Eq. 5 assumes that the donor decay is the same
in both phases, which is a good approximation (see
Section 3.1). Also assumed is that R0 is equal for
every donor^acceptor pair, which is a good approx-
imation (see end of Section 2). The actual R0 value is
not crucially important, and its only e¡ect is on the
absolute values of the recovered c parameters (not
their relative values). Thus small errors in R0 (possi-
bly arising from uncertainty in U2 and n in Eq. 2) are
not critical for the discussion. Donor decays of sam-
ples containing no acceptor or 0.5 mol% ORB were
analyzed together (global analysis [4,16]) for better
recovery of parameters. The results of the analysis
are shown in Table 1, and typical decay curves, ¢t-
ting functions, and residuals distributions (for
xchol = 0.20, T = 30‡C) are shown in Fig. 6.
For xchol = 0, satisfactory ¢ts are obtained ¢xing
Alo = 0 (as expected, being a £uid phase of a pure
phospholipid [16]), and M2 improves non-signi¢cantly
(6 1%) when Alo is optimized (not shown). However,
for xchol = 0.40, when a second c parameter is al-
lowed, M2 improves by 7^17%, and one recovers an
increased c (by V40%) and an additional c value of
0 (with V15% relative weight; not shown). This in-
dicates that, while for the ld phase the probe distri-
bution is essentially random, this is no longer the
case for the lo phase. The use of two c (clo and cld)
parameters in analysis in the phase coexistence range
(xchol = 0.15, 0.20, and 0.25) also leads to V10^20%
improvement in M2, as expected for biphasic samples.
From the recovered Ai and ci values it is possible
to estimate the partition coe⁄cients of donor and
acceptor (respectively) between the two phases, as
recently shown for a gel/£uid mixture [4]. The rele-
vant equations for the Kp of acceptor (KpA) and do-
nor (KpD) are:
KpA  cloWalo=cldWald 7
KpD  Alo=X lo=Ald=X ld 8
where ai is the average area per lipid molecule in
phase i. These were calculated taking into account
the bilayer condensation e¡ect produced by choles-
terol [23], together with the area per DMPC molecule
in pure bilayers [22], and the values ald(30‡C) = 60.1
Aî 2, alo(30‡C) = 48.8 Aî 2, ald(40‡C) = 53.5 Aî 2, and
alo(40‡C) = 45.2 Aî 2 were considered. Using Eqs. 7
and 8 and averaging for the three compositions in-
side the coexistence range, one obtains KpA(30‡C) =
0.057, KpA(40‡C)6 0.01, KpD(30‡C) = 0.32 and
KpD(40‡C) = 0.36 (in this last value, the xchol = 0.15
sample was not included, due to it being very close
to the phase coexistence boundary, leading to large
errors in Xld and KpD from Eq. 8).
4. Discussion
Quite interesting variations in photophysical pa-
rameters of both probes upon the addition of choles-
terol were observed, and they can be rationalized by
taking into account the properties of the NBD and
rhodamine £uorophores. The hypsochromatic shift
observed in NBD-cholesterol £uorescence spectra
upon increasing xchol is probably due to the reduc-
tion of permeability of the bilayer interior to water.
The accessibility of the water molecules to the bilayer
interior is drastically reduced upon increasing the
cholesterol content [24,25]. The polarity of the
NBD-cholesterol £uorophore microenvironment is
thus reduced, leading to shorter maximal wave-
Fig. 6. Fluorescence decay curve of NBD-cholesterol (0.1
mol%) in LUV of DMPC/cholesterol (xchol = 0.20) at T = 30‡C.
Also shown are the ¢tting curves (Eqs. 5 and 6) and the laser
pulse pro¢le. (Inset) Distributions of residuals. (a) no acceptor;
(b): 0.5 mol% of ORB.
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lengths [26,27]. The most striking feature, however, is
the reduction in £uorescence intensity with increasing
xchol. This phenomenon, together with the relative
invariance of Gdf, shows the existence of static self-
quenching of this probe in the lo phase. The self-
quenching of NBD £uorescence for very high local
concentrations and/or aggregation is documented in
the literature [28].
Contrary to NBD-cholesterol, the absorption spec-
trum of ORB shifts bathochromatically as xchol in-
creases (Fig. 4A). The maximum abscissa approaches
the value in bu¡er, indicating that the chromophore
becomes more solvated. This e¡ect is probably due
to steric restrictions caused by the cholesterol mole-
cules, which act as spacers between phospholipid
molecules, reducing their intermolecular interactions,
and rendering their headgroups more accessible to
the solvent [25]. On the other hand, the same phe-
nomenon may be related to the excitonic interaction,
apparent from the relatively enhanced shoulder in
ORB absorption at V530 nm for high xchol. The
probable non-£uorescent nature of these aggregates
explains the invariant £uorescence lifetime and emis-
sion maximum (on one hand) and the signi¢cant re-
duction of £uorescence intensity (on the other hand)
upon increasing xchol. The enhanced dynamic self-
quenching of ORB measured for xchol = 0.40 (where
the di¡usion is slower) relative to pure DMPC
vesicles should be due to non-random ORB distribu-
tion in the lo phase.
Regarding the time-resolved FRET analysis, the
results are compatible with the recovery of Kp6 1
for both probes from the IF variation. In fact, for
the acceptor, the concentration in the lo phase is al-
ways smaller than that in the ld phase (clo6 cld). For
the donor, it is clear that the ratio of molecules in the
lo phase relative to those in the ld phase (given by
Alo/Ald) is consistently 6 1 (even when the lo phase
is predominant, i.e. for xchol = 0.25). The actual
FRET KpD values agree quantitatively with those
of Section 3.1, but there is only qualitative agreement
for KpA. While both types of studies predict that
ORB prefers the ld phase, the FRET data suggest
complete ORB segregation for some samples. This
results from the consistent recovery of a very small
c value (often 0) in the phase coexistence range, and
another larger than those of the monophasic samples
(see Table 1). The fact that relative weight (given by
Alo/Ald) of the FRET component characterized by
cW0 increases with xchol allows its de¢nite assign-
ment to donors located in the lo phase. Thus, £uo-
rescent donors in the lo phase are either isolated
from acceptors or surrounded by a smaller acceptor
local concentration. Note that due to the approxima-
tion made in the FRET analysis procedure (invari-
ance of donor decay with xchol), and despite the re-
covery of clo = 0 in some cases, one cannot state that
these donors are de¢nitely isolated, and that accep-
tors are completely segregated from the lo phase. In
fact, in other samples clos 0 is recovered. It is pos-
sible that one is not capable to distinguish clo = 0
from a situation characterized by a small (much
smaller than cld) but ¢nite clo value, due to the re-
ferred approximation.
In any case, the recovery of an isolated donor
component indicates probe aggregation in the lo
phase [29,30], in agreement with the studies in Sec-
tion 3.1 (namely the reduction of £uorescence inten-
sity). If the aggregates involve a large proportion of
molecules and/or are located near ld/lo interphase
regions (which is probable, given the molecules’ pref-
erence for the ld phase), this aggregation will lead to
a considerable rarefaction of probe molecules in the
interior of the lo phase. Naturally, not all molecules
aggregate in this phase, because IF does not decrease
to zero, even for xchol = 0.4. The £uorescent donors in
this phase would sense a reduced acceptor concen-
tration that, under the FRET analysis approxima-
tions, could be confused with e¡ective isolation.
The main conclusion from both the photophysical
(Section 3.1) and FRET (Section 3.2) studies is that
the probes aggregate signi¢cantly in the lo phase,
which was not expected. Bearing in mind that
NBD-cholesterol is commercialized as a £uorescent
cholesterol analog, it would be reasonable to expect a
priori that this probe would emulate the behavior of
cholesterol, thus preferring the lo phase (from Fig. 1,
one can estimate Kp(cholesterol, 30‡C)W3 and
Kp(cholesterol, 40‡C)W2). However, this work al-
lowed us to establish the inadequacy of this molecule
to mimic cholesterol partition behavior in a phos-
pholipid/cholesterol mixture (Kp(NBD-cholesterol)
I1). It agrees with recent reports that sterols la-
beled with a NBD moiety show anomalous distribu-
tions in living cells [13] and are excluded from cho-
lesterol-rich vesicles [14]. The preference of NBD-
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cholesterol for the ld phase is probably due to the
bulky polar NBD group, which cannot be properly
accommodated in a more tightly packed medium
such as the lo phase. This is an important conclusion,
and future research in phospholipid/cholesterol bi-
layers using photophysical techniques should use ei-
ther sterols with larger structural similarity to that of
cholesterol (such as dehydroergosterol [29,31], or the
even more closely matched cholestatrienol [32]), or,
subject to testing, head-labeled phospholipids which
may not aggregate signi¢cantly in the lo phase. Fluo-
rescence studies involving these kinds of probes in
phospholipid/sterol systems are currently under way.
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